Trends in and Risk Factors for Drug Resistance in Mycobacterium tuberculosis in HIV-Infected Patients

Xiaoqin Le,Xueqin Qian,Li Liu,Jianjun Sun,Wei Song,Tangkai Qi,Zhenyan Wang,Yang Tang,Shuibao Xu,Junyang Yang,Jiangrong Wang,Jun Chen,Renfang Zhang,Zhaoqin Zhu,Yinzhong Shen

DOI: https://doi.org/10.3390/v16040627

2024-04-19

Viruses

Abstract:Trends in and risk factors for drug resistance in Mycobacterium tuberculosis (M. tuberculosis) in human immunodeficiency virus (HIV)-infected patients with active tuberculosis were analyzed. The clinical data of M. tuberculosis and HIV-coinfected patients treated at the Shanghai Public Health Clinical Center between 2010 and 2022 were collected. The diagnosis of tuberculosis was confirmed by solid or liquid culture. The phenotypic drug susceptibility test was carried out via the proportional method, and the resistance to first-line and second-line drugs was analyzed. Logistic regression analysis was performed to identify associated risk factors for drug resistance in M. tuberculosis. Of the 304 patients with a M. tuberculosis-positive culture and first-line drug susceptibility test results, 114 (37.5%) were resistant to at least one first-line anti-tuberculosis drug. Of the 93 patients with first-line and second-line drug susceptibility test results, 40 (43%) were resistant to at least one anti-tuberculosis drug, and 20 (21.5%), 27 (29.0%), 19 (20.4%), 16 (17.2%), and 14 (15.1%) were resistant to rifampicin, streptomycin, ofloxacin, levofloxacin, and moxifloxacin, respectively; 17 patients (18.3%) had multidrug-resistant tuberculosis (MDR-TB). Between 2010 and 2021, the rate of resistance to streptomycin and rifampicin ranged from 14.3% to 40.0% and from 8.0% to 26.3%, respectively, showing an increasing trend year by year. From 2016 to 2021, the rate of resistance to quinolones fluctuated between 7.7% and 27.8%, exhibiting an overall upward trend. Logistic regression analysis showed that being aged <60 years old was a risk factor for streptomycin resistance, mono-drug resistance, and any-drug resistance (RR 4.139, p = 0.023; RR 7.734, p = 0.047; RR 3.733, p = 0.009). Retreatment tuberculosis was a risk factor for resistance to rifampicin, ofloxacin, of levofloxacin (RR 2.984, p = 0.047; RR 4.517, p = 0.038; RR 6.277, p = 0.014). The drug resistance rates of M. tuberculosis to rifampicin and to quinolones in HIV/AIDS patients were high and have been increasing year by year. Age and a history of previous anti-tuberculosis treatment were the main factors associated with the development of drug resistance in HIV/AIDS patients with tuberculosis.

virology

What problem does this paper attempt to address?

This paper aims to analyze the drug - resistance trend of Mycobacterium tuberculosis (M. tuberculosis) and its risk factors among HIV - infected patients treated at the Shanghai Public Health Clinical Center in China from 2010 to 2022. Specifically, the study focused on the following points:

1. **Drug - resistance trend**: The study analyzed the trend of the resistance rate of M. tuberculosis to first - line and second - line anti - tuberculosis drugs over time. The results showed that from 2010 to 2021, the resistance rates of streptomycin and rifampicin increased year by year, and the resistance rate of quinolones also showed an overall upward trend from 2016 to 2021.

2. **Drug - resistance characteristics**: The study collected the clinical data of 304 patients and the sensitivity test results of first - line anti - tuberculosis drugs. Among them, 114 patients (37.5%) were resistant to at least one first - line anti - tuberculosis drug. Among 93 patients who underwent both first - line and second - line drug sensitivity tests, 40 patients (43%) were resistant to at least one anti - tuberculosis drug, of which 20 patients (21.5%) were resistant to rifampicin, 27 patients (29.0%) were resistant to streptomycin, 19 patients (20.4%) were resistant to ofloxacin, 16 patients (17.2%) were resistant to levofloxacin, and 14 patients (15.1%) were resistant to moxifloxacin. In addition, 17 patients (18.3%) had multi - drug - resistant tuberculosis (MDR - TB).

3. **Risk factors**: Through binary logistic regression analysis, the study identified risk factors related to drug resistance. The results showed that being younger than 60 years old was a risk factor for streptomycin resistance, single - drug resistance, and any - drug resistance (the relative risk ratios were 4.139, p = 0.023; 7.734, p = 0.047; 3.733, p = 0.009, respectively). Retreatment of tuberculosis was a risk factor for rifampicin resistance, ofloxacin resistance, and levofloxacin resistance (the relative risk ratios were 2.984, p = 0.047; 4.517, p = 0.038; 6.277, p = 0.014, respectively).

In conclusion, through detailed data analysis, this paper reveals the drug - resistance trend of M. tuberculosis in HIV - infected patients and its related risk factors, providing a scientific basis for formulating effective prevention and control measures.